Tailoring treatment for cancer patients
- April 16, 2018
A research team led by BIGHEART Acting Director Prof. Lim Chwee Teck has developed a device which can grow tumour clusters from circulating cancer cells in blood, for personalised drug testing and treatment. The device is faster than other current methods, taking two weeks to grow tumour clusters of sufficient size instead of around six months, and has more than twice the cluster formation success rate compared to other methods. (https://www.nature.com/articles/nprot.2017.125)
In another study, Prof. Lim and his team analysed tumours of more than 2,000 patients with early-stage non-small cell lung cancer (NSCLC) and identified 29 genes that can be used to predict patient response to treatment and for targeted therapeutic approaches. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700969/)
Please click the links below for the news articles:
